Pramodini Medicare IPO Day 1: Subscription status, review — here's what you need to know
Pramodini Medicare IPO opens with a price band of ₹110.00000-₹118.00000. Day 1 subscription stands at 0.75x overall, led by QIBs at 1.81x. Issue size ranges from ₹396000 to ₹500000 with a min bid qty of 2400.

*this image is generated using AI for illustrative purposes only.
Pramodini Medicare IPO opened for subscription today, marking the beginning of its public offering journey. Investors can now apply for the shares within the specified price band as the company seeks to raise capital through this initial public offering.
Subscription Status
On Day 1, the Pramodini Medicare IPO recorded a total subscription of 0.75 x. Qualified Institutional Buyers (QIBs) showed the highest interest among investor categories, subscribing to 1.81 x of their quota. Non-Institutional Buyers (bHNI) subscribed to 0.26 x, while Non-Institutional Buyers (sHNI) accounted for 0.15 x. Retail investors and Employees category subscriptions were reported at 0 x on the first day.
| Category | Subscription Multiple |
|---|---|
| QIB | 1.81 x |
| NII (bHNI) | 0.26 x |
| NII (sHNI) | 0.15 x |
| Retail | 0 x |
| Employees | 0 x |
| Total | 0.75 x |
About the Company
Pramodini Medicare is entering the public markets with an issue size ranging from ₹396000 to ₹500000. The company operates in the healthcare sector, aiming to leverage the capital raised from this IPO for its business operations and growth initiatives. Key financial details and broader operational metrics are outlined in the offer documents filed with regulators.
Offer Details
The IPO is priced with a floor price of ₹110.00000 and a ceiling price of ₹118.00000. The minimum bid quantity required for application is 2400 units. The issue size is structured between a minimum of ₹396000 and a maximum of ₹500000. Investors are advised to check the official allotment portal and exchange websites for further updates on the subscription timeline and listing details.
How might the strong initial interest from QIBs influence the final listing price and trading volume in the first week?
What specific growth initiatives or debt repayment plans is Pramodini Medicare prioritizing with the capital raised from this IPO?
Given the zero subscription from retail investors on Day 1, what factors might be driving retail hesitation compared to institutional confidence?



























